These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


696 related items for PubMed ID: 22273720

  • 21. [Post-transplant lymphoproliferative disorders in renal transplantation: two decades of experience].
    Franco A, Jiménez L, Sillero C, Trigueros M, González D, Alcaraz E, Olivares J.
    Nefrologia; 2010; 30(6):669-75. PubMed ID: 21113217
    [Abstract] [Full Text] [Related]

  • 22. The OPTN/UNOS renal transplant registry.
    Cecka JM.
    Clin Transpl; 2004; ():1-16. PubMed ID: 16704134
    [Abstract] [Full Text] [Related]

  • 23. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M, Badwal S, Pandey R, Srivastava A, Sharma RK, Gupta RK.
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [Abstract] [Full Text] [Related]

  • 24. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
    Opelz G, Daniel V, Naujokat C, Döhler B.
    Transplantation; 2009 Oct 27; 88(8):962-7. PubMed ID: 19855238
    [Abstract] [Full Text] [Related]

  • 25. Post-transplant lymphoproliferative disorder following pediatric heart transplantation.
    Mendoza F, Kunitake H, Laks H, Odim J.
    Pediatr Transplant; 2006 Feb 27; 10(1):60-6. PubMed ID: 16499589
    [Abstract] [Full Text] [Related]

  • 26. Molecular epidemiology of Epstein-Barr virus in adult kidney transplant recipients.
    Cavallo R, Elia M, Gruosso V, Curtoni A, Costa C, Bergallo M.
    Transplant Proc; 2010 Sep 27; 42(7):2527-30. PubMed ID: 20832536
    [Abstract] [Full Text] [Related]

  • 27. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
    Leung E, Shenton BK, Green K, Jackson G, Gould FK, Yap C, Talbot D.
    Transpl Infect Dis; 2004 Dec 27; 6(4):156-64. PubMed ID: 15762933
    [Abstract] [Full Text] [Related]

  • 28. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 27; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 29. Adolescents are more likely to develop posttransplant lymphoproliferative disorder after primary Epstein-Barr virus infection than younger renal transplant recipients.
    Smith JM, Corey L, Healey PJ, Davis CL, McDonald RA.
    Transplantation; 2007 Jun 15; 83(11):1423-8. PubMed ID: 17565314
    [Abstract] [Full Text] [Related]

  • 30. Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantation.
    Kalra A, Roessner C, Jupp J, Williamson T, Tellier R, Chaudhry A, Khan F, Taparia M, Jimenez-Zepeda VH, Stewart DA, Daly A, Storek J.
    Clin Transplant; 2018 Jan 15; 32(1):. PubMed ID: 29114932
    [Abstract] [Full Text] [Related]

  • 31. Lytic and latent EBV gene expression in transplant recipients with and without post-transplant lymphoproliferative disorder.
    Kroll J, Li S, Levi M, Weinberg A.
    J Clin Virol; 2011 Nov 15; 52(3):231-5. PubMed ID: 21900040
    [Abstract] [Full Text] [Related]

  • 32. Associations of serum EBV DNA and gammopathy with post-transplant lymphoproliferative disease.
    Rosselet A, Vu DH, Meylan P, Chaubert AS, Schapira M, Pascual M, Aubert V, Tissot JD, Duchosal MA.
    Clin Transplant; 2009 Nov 15; 23(1):74-82. PubMed ID: 19200218
    [Abstract] [Full Text] [Related]

  • 33. Cytomegalovirus & Epstein Barr Virus serostatus as a predictor of the long-term outcome of kidney transplantation.
    Le Page AK, Mackie FE, McTaggart SJ, Kennedy SE.
    Nephrology (Carlton); 2013 Dec 15; 18(12):813-9. PubMed ID: 23927085
    [Abstract] [Full Text] [Related]

  • 34. Pretransplant prophylactic rituximab to prevent Epstein-Barr virus (EBV) viremia in EBV-seronegative kidney transplant recipients from EBV-seropositive donors: results of a pilot study.
    Schachtner T, Reinke P.
    Transpl Infect Dis; 2016 Dec 15; 18(6):881-888. PubMed ID: 27632022
    [Abstract] [Full Text] [Related]

  • 35. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.
    J Heart Lung Transplant; 1998 Dec 15; 17(12):1161-6. PubMed ID: 9883755
    [Abstract] [Full Text] [Related]

  • 36. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation.
    Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT.
    Pediatr Transplant; 2004 Jun 15; 8(3):267-72. PubMed ID: 15176965
    [Abstract] [Full Text] [Related]

  • 37. Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.
    Aris RM, Maia DM, Neuringer IP, Gott K, Kiley S, Gertis K, Handy J.
    Am J Respir Crit Care Med; 1996 Dec 15; 154(6 Pt 1):1712-7. PubMed ID: 8970360
    [Abstract] [Full Text] [Related]

  • 38. Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies.
    Gao XN, Lin J, Wang LJ, Li F, Li HH, Wang SH, Huang WR, Gao CJ, Yu L, Liu DH.
    Ann Hematol; 2019 Sep 15; 98(9):2163-2177. PubMed ID: 31243569
    [Abstract] [Full Text] [Related]

  • 39. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients.
    Wareham NE, Mocroft A, Sengeløv H, Da Cunha-Bang C, Gustafsson F, Heilmann C, Iversen M, Kirkby NS, Rasmussen A, Sørensen SS, Lundgren JD, MATCH in PERSIMUNE study group.
    J Cancer Res Clin Oncol; 2018 Aug 15; 144(8):1569-1580. PubMed ID: 29804164
    [Abstract] [Full Text] [Related]

  • 40. Adenotonsillar hypertrophy and Epstein-Barr virus in pediatric organ transplant recipients.
    Shapiro NL, Strocker AM.
    Laryngoscope; 2001 Jun 15; 111(6):997-1001. PubMed ID: 11404611
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 35.